Immunisation of the travelling child sciencedirect. Action note that the recommendations given in this update supersede the advice given in da200209 on 7 august 2002. Meningococcal group b vaccine meningitis research foundation. Influenzae meningitis notifiable except in scotland.
Travellers whose planned activities or medical conditions put them at increased risk of meningococcal disease should consider vaccination with the quadrivalent conjugate vaccine. Meningococcal c vaccine for protection against meningitis. As of june 2011, reports projected that the meningitis. Infants residing in these countries may consider meningococcal vaccination according to the routine immunization.
Phe uk immunisation schedule green book chapter 11. The meningitis b vaccine is a vaccine that offers protection against meningococcal group b bacteria, which are a common cause of meningitis in young children in the uk. Information about meningococcal disease, vaccines and recommendations for vaccination from the australian immunisation handbook. Current epidemic strategy and new perspectives suzanne chanteau, angela m. If you use assistive technology such as a screen reader and need a version of this document in a more accessible format. This is the third in a series of three papers about bacterial meningitis. Vaccination for certain groups of people is funded under the national immunisation program and by states and territories. An anaphylaxis pack normally contains two ampoules of adrenaline. This summary covers types of vaccine, administration, dosage and schedule, and atrisk groups who should be immunised against.
Effect of vaccines on bacterial meningitis worldwide. From 1990, new zealand experienced an epidemic of serogroup b meningococcal disease, but has had a significant reduction in cases since a vaccination program in 200405. Immunization schedules red book online aap pointof. Between 2010 and 2014, the vaccine was given to more than 220 million children in 15 countries. For the latest immunisation advice, always refer to the green book. The african meningitis belt is a region in subsaharan africa where the rate of incidence of meningitis is very high. Although endemic in various regions across the globe, the imd burden is greatest in the 22 countries comprising the meningitis belt of subsaharan africa. The pattern of epidemic meningococcal disease in subsaharan africa is well described. Neisseria meningitidis is a leading causative agent of bacterial meningitis and septicemia, particularly in children immunisation schedule in the public health england phe document immunisation against infectious disease green book to include hpv vaccination in all children aged 12 years and flu vaccination. In 2010, a newly developed meningococcal a conjugate vaccine, known as menafrivac, was introduced to countries in the meningitis belt. Starting in 2010, meningitis belt countries began implementing mass vaccination campaigns for a monovalent serogroup a meningococcal conjugate vaccine. The uk was the first country to launch a national meningococcal conjugate vaccination program in 1999 using a serogroup c vaccine, resulting in a dramatic decline in serogroup c disease. Phe pneumococcal guideline green book chapter 25 phedh.
Meningococcal disease is a rare, but potentially devastating infection. Immunisation of individuals with underlying medical conditions chapter 7 immunisation of individuals with underlying medical conditionsanuary 22 prematurity it is important that premature infants have their immunisations at the appropriate chronological age, according to the schedule. The advisory committee on immunization practices acip develops recommendations on how to use vaccines to control disease in the united states. The hibcontaining vaccine pediacel chosen for primary immunisation in the uk programme has been shown not to have this problem miller et al. In the meningitis belt, serogroup a historically accounted for 90% of meningococcal disease cases and the majority of largescale epidemics. Serogroup a vaccine in the african meningitis belt. Immunisation of individuals with underlying medical conditions. The green book has the latest information on vaccines and vaccination procedures, for vaccine preventable infectious diseases in the uk. Since september 2015 uk babies born on or after 1 july 2015 have been offered the menb meningococcal group b vaccine as part of the routine immunisation schedule and babies born on or after 1 may were offered the vaccine. Vaccine safety and the management of adverse events. Its impact was seen immediately in 2014 there were no new cases of meningitis. Only meningococcal b infection is prevented by the menb vaccine. Other types of meningococcal infection are not covered by this vaccine.
Meningococcal conjugate vaccination programs in the meningitis belt are just beginning and have potential to eliminate epidemic serogroup a meningococcal disease as a public health concern in the region. Phe uk immunisation schedule green book chapter 11 phedh. Immunisation against infectious diseasethe green book uk. Always make recommendations by determining needed vaccines based on age table 1, determining appropriate intervals for catchup, if needed table 2, assessing for medical indications table 3. Advice on menveo dose schedule for infants travelling to areas with high meningococcal a activity has been added.
Meningococcal immunisation information for public health professionals. The routine infant meningococcal b menb vaccine against meningitis and septicaemia in the uk and ireland babies are offered the menb meningococcal group b vaccine, bexsero, as part of the routine immunisation. The routine infant meningococcal b menb vaccine against. If you use assistive technology such as a screen reader and need a version of this document in a more. The african meningitis belt, which extends from senegal to ethiopia, includes more than 350 million people and accounts for the highest meningococcal disease burden worldwide.
Vaccination strategies for the prevention of meningococcal. Vaccine safety and the management of adverse events following immunisation august 2012. The disease is most common in the meningitis belt of subsaharan africa, which. Serogroup a is responsible for most of the meningococcal disease in subsaharan africa. These upsurges are usually associated with the introduction of novel subtypes andor. Primary prevention of meningitis is paramount, since death and longterm disabling sequelae are substantial in all settings. Meningococcal carriage in the african meningitis belt. Meningococcal meningitis in the african meningitis belt. Action note that the recommendations given in this update supersede the advice given in da200209 on 7 august 2002 and. Mmr is a safe and effective combined vaccine that protects against 3 separate illnesses measles, mumps and rubella german measles in a single injection. Meningococcal disease occurs throughout the world, but is more common in the area of africa known as the meningitis belt. Menafrivac tm use of vaccine in pregnant and lactating women.
Biological diagnosis of meningococcal meningitis in the african meningitis belt. Meningococcal disease in the middle east and africa. The meningitis vaccine project was conceived in 2001 as an effort to stop the spread of meningitis in this region. Vaccine resources cdc health information for international travel 2008 yellow book. Three primary doses should be given with an interval of 8 weeks between doses, followed by a 4th dose at 12.
Does the meningococcal b menb vaccine protect against all meningococcal disease. The information on available types of hepatitis a vaccine and vaccination schedules is based on expert opinion in the department of health publication immunisation against infectious disease the green book. Vaccinations are important to both maternal and child health. For babies born on or after 1 october 2016, the time of giving menc vaccine has been changed from 4 months to 6 months to allow babies get the menb vaccine at 2 and 4 months for earlier protection. The vaccine strategy is to target 129 year olds in a mass immunisation. The meningitis vaccine projects serogroup a conjugate vaccine will first be introduced into burkina faso in 200910 in a demonstration project, before being rolled out across other countries of the meningitis belt 35. The fully revised and updated cdc yellow book 2020 compiles the us governments most current travel health guidelines, including pretravel vaccine recommendations, destinationspecific health advice, and easytoreference maps, tables, and charts. In some countries outside the meningitis belt, meningococcal vaccination such as monovalent conjugate c vaccine or menb vaccine may be recommended as part of the routine immunization program for infants. This illness can cause meningitis, an infection of the lining around the brain or spinal cord. Get the latest updates and information for gps about. What do you do if a patients immunisation status is incomplete or unknown.
There is a marked seasonal variation in meningococcal disease, with peak levels in the winter months declining to low levels by late summer. Recommendations for immunisation of infants and children aged vaccines. Advisories for travelers to other countries are issued when outbreaks of meningococcal disease are. The overall aim of the uks routine immunisation schedule is to provide protection against the following vaccinepreventable infections. A limited number of travel vaccines are provided on the nhs for public health reasons. Immunisation against infectious disease the green book. The vaccine is recommended for babies aged 8 weeks, followed by a second dose at 16 weeks and a booster at 1 year.
978 927 1436 1141 171 1292 1409 106 759 95 1284 685 1518 1530 24 1520 1418 73 1338 266 1561 223 162 26 1302 343 1081 1512 1241 569 604 864 1110 1399 1318 363 1599 390 1526 1375 807 1376 1330 393 304 185 1452 247 204